Custom-Curated Report: 
Don't be the VC that bleeds money

Make data-backed investment decisions.

Whether you're drowning in complex patent documents or struggling to make sense of market data, Perceive Now AGI simplifies your research and uncovers opportunities.Customize your analysis in minutes – empowering you to scale your IP strategy  and untapped possibilities.

Start new conversation

Generate new report

User info



Executive Summary of Tissue Regeneration Report VC Investment Insights
Market Overview and Growth Prospects

The tissue regeneration market has reached a pivotal USD 14.83 billion in valuation as of 2022. With a CAGR of 14.28% predicted through 2030, the potential market size is forecasted to exceed USD 35 billion. This growth is anchored by a 20% annual increase in the incidence of targetable chronic conditions, driving a surge in demand for regenerative treatments. Market segments such as stem cell therapies and 3D bioprinting are expected to witness a 25% and 30% increase in market share respectively, within the forecast period.

Investment Landscape

The past year saw venture capital investment cross the USD 2 billion threshold, signifying a robust influx of capital into the sector. The number of early-stage deals has grown by 18%, while later-stage investments saw a 22% increase in average deal size, demonstrating investor confidence and the maturing of the industry. Strategic investments, such as Sartorius's USD 49.91 million investment in BICO, represent a growing preference for equity stakes in companies with scalable and collaborative potential, indicating a shift towards long-term, growth-oriented partnerships.

Government Funding and R&D Impact

Governmental support has become more pronounced, with an overall 30% increase in R&D funding, signaling strong endorsement for the industry's potential. The funds are often earmarked for translational research, which has seen a boost in grant availability. As a result, the speed of innovation has accelerated, with R&D cycles shortening by an estimated 15%, predicated on the streamlining of regulatory pathways and the optimization of research methodologies.

Why our customers prefer Perceive Now


Accelerated IP and market analysis.


Decrease in risky startup investments.


Increase in revealing lucrative market potential .


Faster identification of viable IP licensing pathways.


Faster identification of M&A targets.

How it works?

48 hour
Chat with or AI
Chat with or AI

Tell us your story and needs!
Start a conversation with our AI.

Tailored IP and Market Intelligence
Tailored IP and Market Intelligence

Our context-rich lens cuts through the noise
and distills what matters for your key priorities.

Reports are Ready
Reports are Ready

Land custom-crafted, context-rich
and accurate reports to power your strategy
in 48 hours.

Transform your IP and market haziness into competitive gold, now.

With Perceive Now AGI, complex research is a breeze, letting you focus on growth strategies with ease.

IP analysis
Prior art search
Freedom to Operate
Patentability opinion
Patent validity/invalidity
Patent infringement
IP analysis
Investment Landscape
and M&A trends
IP licensing targets
Exit potential and comparable
M&A trends and opportunities
Investment Landscape <br/> and M&A trends
Market potential assessment
Market Opportunities and Growth
Competitive positioning
Consumer preferences and buying habits
Regulatory compliance and risk mitigation
Technology commercialization assessment
Market potential assessment
Innovation and Sustainability
in Product Development
New product opportunities - R&D
Sustainability strategies
M&A projections
Innovation and Sustainability <br/> in Product Development

No more tedious analysis, Perceive Now shows you how.


From patentability to market research, it's all at your fingertips, now.


Say goodbye to “research overwhelm”, accelerate your deal flow, now.


Spend less time searching, and more time implementing, now!

Perceive now LLM pinpoints the exact language and clauses I need for a watertight IP licensing agreement with a med-tech startup. This tool has saved me countless billable hours and gives me the confidence to secure the best deal for my clients.

Leading IP Law Firm

We were missing out on promising biotech startups because their patent filings were just too dense. Perceive now doesn't just surface relevant patents – it actually analyzes them for potential commercialization routes we hadn't even considered

Leading Venture Capital Firm

Honestly, I was skeptical that an AI tool could replace our team’s gut instincts for spotting potential acquisitions. But in the last six months, its analysis of a startup's patent portfolio revealed a licensing opportunity worth millions that we would have completely overlooked. This platform is now an integral part of our M&A process.

Leading PE Firm

Let Perceive Now AGI
power your next

See what others miss.
Upgrade your diligence,


Already have an account?Sign In

Find us on:
Subscribe to PerceiveNow Insights